default author photo

Bruno Pozzetto

University of Claude Bernard Lyon 1 - CIRI

Lyon, F-69372

France

  • University of Claude Bernard Lyon 1 - CIRI

SCHOLARLY PAPERS

3

DOWNLOADS

271

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Impact of SARS-CoV-2 Vaccine and Infection History on Antiviral Immunity Post Breakthrough Infection

Number of pages: 26 Posted: 17 May 2024
Carla Saade, Timothée Bruel, Lou-Léna Vrignaud, Martin Killian, Annabelle Drouillard, Véronique Barateau, Maxime Espi, Natacha Mariano, Charlotte Mignon, Lily Bruyère, Liliane Khoryati, William Henry Bolland, Olivier Schwartz, Bruno Lina, Martine Valette, Olivier Thaunat, Jean-Baptiste Fassier, COVID-Ser study group, Bruno Pozzetto, Stephane Paul, Thierry Walzer and Sophie Assant
University of Claude Bernard Lyon 1 - CIRI, Institut Pasteur - Virus & Immunity Unit, University of Paris-Saclay - Institut Pasteur, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, BIOASTER, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Claude Bernard Lyon 1 - CIRI, Hospices Civils de Lyon, University of Claude Bernard Lyon 1 - CIRI, Hospices Civils de Lyon - Occupational Health and Medicine Department, Hospices Civils de Lyon, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI and Hospices Civils de Lyon - Laboratoire de Virologie
Downloads 124 (580,653)

Abstract:

Loading...

SARS-CoV-2, breakthrough infection, hybrid immunity, immune trajectory, IgG4 class-switching, ADCC function

2.

Vaccination Induces Stronger Spike Immunity and Better Protection Against SARS-CoV-2 Infection in COVID-19 Recovered Subjects than in Naïve Individuals

Number of pages: 34 Posted: 13 Jan 2022
Nicolas Guibert, Carla Saade, Karen Brengel-Pesce, Mad-Hélénie Elsensohn, Bruno Pozzetto, Christelle Compagnon, Véronique Barateau, Natacha Mariano, Julie Chaix, Sophia Djebali, Loïc Peyrot, Jean-Baptiste Fassier, Bruno Lina, Jacqueline Marvel, Manuel Rosa-Calatrava, Delphine Maucort-Boulch, Laetitia Henaff, Mitra Saadatian-Elahi, Philippe Vanhems, Stephane Paul, Thierry Defrance, Thierry Walzer and Sophie Assant
Hospices Civils de Lyon - Occupational Health and Medicine Department, University of Claude Bernard Lyon 1 - CIRI, Lyon Sud Hospital - Joint Research Unit Civils Hospices of Lyon-bioMérieux, Hospices Civils de Lyon - Service de Biostatistique, University of Claude Bernard Lyon 1 - CIRI, Lyon Sud Hospital - Joint Research Unit Civils Hospices of Lyon-bioMérieux, University of Claude Bernard Lyon 1 - CIRI, BIOASTER, BIOASTER, Université Lyon 1 - Centre International de Recherche en Infectiologie (CIRI), University of Claude Bernard Lyon 1 - CIRI, Hospices Civils de Lyon - Occupational Health and Medicine Department, University of Claude Bernard Lyon 1 - CIRI, Université Lyon 1 - Centre International de Recherche en Infectiologie (CIRI), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Hospices Civils de Lyon - Service de Biostatistique, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI, University of Claude Bernard Lyon 1 - CIRI and Hospices Civils de Lyon - Laboratoire de Virologie
Downloads 117 (608,822)

Abstract:

Loading...

Covid-19vaccinationantibodiesneutralizing antibodiesvirus-specific T cellsvaccine effectiveness

3.

Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in Seropositive Subjects

Number of pages: 17 Posted: 03 Feb 2022
Kahina Saker, Bruno Pozzetto, Vanessa Escuret, Virginie Pitiot, Amélie Massardier-Pilonchery, Bouchra Mokdad, Carole Langlois-Jacques, Muriel Rabilloud, Dulce Alfaiate, Nicolas Guibert, Jean-Baptiste Fassier, Antonin Bal, Sophie Assant and Mary-Anne Trabaud
Hospices Civils de Lyon - Laboratoire de Virologie, University of Claude Bernard Lyon 1 - CIRI, Hospices Civils de Lyon - Laboratoire de Virologie, Hospices Civils de Lyon - Occupational Health and Medicine Department, Hospices Civils de Lyon - Occupational Health and Medicine Department, Hospices Civils de Lyon - Laboratoire de Virologie, Université de Lyon - Laboratoire de Biométrie et Biologie Evolutive, Université de Lyon - Laboratoire de Biométrie et Biologie Evolutive, Hospices Civils de Lyon - Occupational Health and Medicine Department, Hospices Civils de Lyon - Occupational Health and Medicine Department, Hospices Civils de Lyon - Occupational Health and Medicine Department, Hospices Civils de Lyon - Laboratoire de Virologie, Hospices Civils de Lyon - Laboratoire de Virologie and Hospices Civils de Lyon - Laboratoire de Virologie
Downloads 30 (1,318,317)

Abstract:

Loading...

SARS-CoV-2, neutralizing antibodies, commercial tests, surrogate markers of protection, competitive anti-RBD immunoassays